RECENT POSTS
Tuesday, June 11, 2019
Not Much Fizz in LaCroix Right Now

Wednesday, May 29, 2019
An Example of Calcbench, Excel, and Insight

Monday, May 20, 2019
Research Paper: Capex Spending

Thursday, May 16, 2019
Psst: Got Any Weed?

Wednesday, May 15, 2019
Open Letter: SEC Proposed Rule for BDCs

Friday, May 10, 2019
General Motors and Workhorse

Monday, May 6, 2019
How to Find Earnings Release Data

Tuesday, April 23, 2019
Following Restructuring Costs Over Time

Monday, April 22, 2019
Capex Spending: More Than You Might Think

Saturday, April 13, 2019
When AWS Takes Over the World

Thursday, April 11, 2019
Data Trends in Focus: Restructuring Costs

Sunday, April 7, 2019
How One Customer Crushed It With Calcbench

Thursday, April 4, 2019
TJX Shows Complexity of Leasing Costs Reporting

Tuesday, April 2, 2019
CEO Pay Ratios: Some 2018 Thoughts

Wednesday, March 27, 2019
Corporate Spending: Where It Goes, 2017 vs. 2018

Monday, March 25, 2019
Health Insurers: A Bit Winded?

Friday, March 22, 2019
Our New Master Class Video

Thursday, March 21, 2019
Tech Data’s Goodwill Adjustment

Tuesday, March 19, 2019
There’s Taxes, and There’s Taxes

Saturday, March 16, 2019
Adventures in Tax Cuts and Net Income

Archive  |  Search:
R&D Big Spenders in 2017
Monday, March 12, 2018

Now that a large majority of S&P 500 firms have filed their 2017 annual reports, Calcbench will occasionally look at some specific line item to see how Corporate America is spending its money.

First up: research and development costs.

Among the 446 companies that have submitted their 2017 reports already, that group spent a collective $228.2 billion on R&D last year — up 5.2 percent from the $216.9 billion that the S&P 500 spent in 2016. That $228.2 billion is 2.26 percent of total revenue for 2017, which was $10.12 trillion.

But watch out! The 2.26 percent is deceptive, because not all S&P 500 companies report R&D costs. Only 172 firms in our sample have reported R&D, and they collectively had only $3.63 trillion in revenue.

When you calculate the $228.2 billion over that smaller group, the portion of revenue devoted to R&D spending among those S&P 500 companies that report any R&D at all jumps to 6.3 percent. That’s the highest percentage we’ve seen in five years. Yay science! (See Fig. 1, below.)

So who are the biggest spenders?

First we ranked companies by total dollars spent on R&D. Don’t die of shock here, but Google topped the list (as it did in 2016, too). Four of the top 10 were tech firms, and five were pharmaceutical firms. Only Ford snuck into the list from an old school manufacturing sector, so we look forward to a flying car or something in 2019. (See Fig. 2, below.)

Next we ranked companies by percentage of revenue spent on R&D. Seven of the top 10 were pharmaceutical firms of some kind, and that’s no surprise either; many pharma and life science firms spend every penny they can find on R&D for years, until that one blockbuster drug gets approved and they start making real profits. (See Fig. 3, below.)

We should add the caveat that several large filers in the S&P 500 have yet to file their 2017 reports. Most notable is Walmart, whose revenue and R&D numbers could alter the averages for the whole group a bit, although not to a material degree.

Calcbench subscribers, meanwhile, can take this information and use it to ask better questions about the companies you follow. For example, you could calculate the average R&D spending for specific companies you follow and then quickly see what their peers spend for R&D. Then you’re well positioned to lob a few tough questions, if necessary, on that next earnings call.


FREE Calcbench Premium
Two Week Trial

Research Financial & Accounting Data Like Never Before. More features and try our Excel add-in. Sign up now to try the Premium Suite.